Cargando…
Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
BACKGROUND: In 2008, the Cochrane Collaboration introduced a tool for assessing the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is based on narrative descriptions of evidence-based methodological features known to increase the risk of bias in trials. MET...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022341/ https://www.ncbi.nlm.nih.gov/pubmed/24731537 http://dx.doi.org/10.1186/2046-4053-3-37 |
_version_ | 1782316386348957696 |
---|---|
author | Savović, Jelena Weeks, Laura Sterne, Jonathan AC Turner, Lucy Altman, Douglas G Moher, David Higgins, Julian PT |
author_facet | Savović, Jelena Weeks, Laura Sterne, Jonathan AC Turner, Lucy Altman, Douglas G Moher, David Higgins, Julian PT |
author_sort | Savović, Jelena |
collection | PubMed |
description | BACKGROUND: In 2008, the Cochrane Collaboration introduced a tool for assessing the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is based on narrative descriptions of evidence-based methodological features known to increase the risk of bias in trials. METHODS: To assess the usability of this tool, we conducted an evaluation by means of focus groups, online surveys and a face-to-face meeting. We obtained feedback from a range of stakeholders within The Cochrane Collaboration regarding their experiences with, and perceptions of, the RoB tool and associated guidance materials. We then assessed this feedback in a face-to-face meeting of experts and stakeholders and made recommendations for improvements and further developments of the RoB tool. RESULTS: The survey attracted 380 responses. Respondents reported taking an average of between 10 and 60 minutes per study to complete their RoB assessments, which 83% deemed acceptable. Most respondents (87% of authors and 95% of editorial staff) thought RoB assessments were an improvement over past approaches to trial quality assessment. Most authors liked the standardized approach (81%) and the ability to provide quotes to support judgements (74%). A third of participants disliked the increased workload and found the wording describing RoB judgements confusing. The RoB domains reported to be the most difficult to assess were incomplete outcome data and selective reporting of outcomes. Authors expressed the need for more guidance on how to incorporate RoB assessments into meta-analyses and review conclusions. Based on this evaluation, recommendations were made for improvements to the RoB tool and the associated guidance. The implementation of these recommendations is currently underway. CONCLUSIONS: Overall, respondents identified positive experiences and perceptions of the RoB tool. Revisions of the tool and associated guidance made in response to this evaluation, and improved provision of training, may improve implementation. |
format | Online Article Text |
id | pubmed-4022341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40223412014-05-16 Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation Savović, Jelena Weeks, Laura Sterne, Jonathan AC Turner, Lucy Altman, Douglas G Moher, David Higgins, Julian PT Syst Rev Research BACKGROUND: In 2008, the Cochrane Collaboration introduced a tool for assessing the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is based on narrative descriptions of evidence-based methodological features known to increase the risk of bias in trials. METHODS: To assess the usability of this tool, we conducted an evaluation by means of focus groups, online surveys and a face-to-face meeting. We obtained feedback from a range of stakeholders within The Cochrane Collaboration regarding their experiences with, and perceptions of, the RoB tool and associated guidance materials. We then assessed this feedback in a face-to-face meeting of experts and stakeholders and made recommendations for improvements and further developments of the RoB tool. RESULTS: The survey attracted 380 responses. Respondents reported taking an average of between 10 and 60 minutes per study to complete their RoB assessments, which 83% deemed acceptable. Most respondents (87% of authors and 95% of editorial staff) thought RoB assessments were an improvement over past approaches to trial quality assessment. Most authors liked the standardized approach (81%) and the ability to provide quotes to support judgements (74%). A third of participants disliked the increased workload and found the wording describing RoB judgements confusing. The RoB domains reported to be the most difficult to assess were incomplete outcome data and selective reporting of outcomes. Authors expressed the need for more guidance on how to incorporate RoB assessments into meta-analyses and review conclusions. Based on this evaluation, recommendations were made for improvements to the RoB tool and the associated guidance. The implementation of these recommendations is currently underway. CONCLUSIONS: Overall, respondents identified positive experiences and perceptions of the RoB tool. Revisions of the tool and associated guidance made in response to this evaluation, and improved provision of training, may improve implementation. BioMed Central 2014-04-15 /pmc/articles/PMC4022341/ /pubmed/24731537 http://dx.doi.org/10.1186/2046-4053-3-37 Text en Copyright © 2014 Savović et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Savović, Jelena Weeks, Laura Sterne, Jonathan AC Turner, Lucy Altman, Douglas G Moher, David Higgins, Julian PT Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
title | Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
title_full | Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
title_fullStr | Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
title_full_unstemmed | Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
title_short | Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
title_sort | evaluation of the cochrane collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022341/ https://www.ncbi.nlm.nih.gov/pubmed/24731537 http://dx.doi.org/10.1186/2046-4053-3-37 |
work_keys_str_mv | AT savovicjelena evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation AT weekslaura evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation AT sternejonathanac evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation AT turnerlucy evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation AT altmandouglasg evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation AT moherdavid evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation AT higginsjulianpt evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation |